ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,214Medicare Part D Prescriptions Filled, Including Refills

Rank: 236 out of 1692

$643K Total Retail Price of All Prescriptions

Rank: 144 out of 1692

457 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 457 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 457 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,712 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 464 430 1 1
LISINOPRIL 332 297 2 2
LEVOTHYROXINE SODIUM 276 227 3 4
AMLODIPINE BESYLATE 200 188 4 3
METFORMIN HCL 188 156 5 8
ATORVASTATIN CALCIUM 164 146 6 11
OMEPRAZOLE 161 120 7 5
ZOLPIDEM TARTRATE 153 122 8 23
SERTRALINE HCL 145 141 9 22
ATENOLOL 135 116 10 15
CRESTOR 133 105 11 26
TAMSULOSIN HCL 131 103 12 31
HYDROCODONE-ACETAMINOPHEN 130 99 S3 13 6
DIOVAN 126 126 14 42
SYNTHROID 114 68 15 59
LOSARTAN POTASSIUM 114 107 15 17
FUROSEMIDE 110 109 17 7
MELOXICAM 108 108 18 41
WARFARIN SODIUM 107 96 19 14
NEXIUM 103 74 20 25
AZITHROMYCIN 100 83 21 34
PRAVASTATIN SODIUM 94 93 22 12
DONEPEZIL HCL 94 94 22 29
DICLOFENAC SODIUM 88 75 24 75
ALLOPURINOL 86 86 25 30
CITALOPRAM HBR 86 64 25 21
METOPROLOL TARTRATE 82 80 27 10
KLOR-CON M20 81 79 28 48
ALENDRONATE SODIUM 79 65 29 36
LEVOFLOXACIN 77 65 30 113
ADVAIR DISKUS 77 60 30 45
BUMETANIDE 76 57 32 125
HYDROCHLOROTHIAZIDE 76 72 32 9
CLOPIDOGREL 75 67 34 43
DOXYCYCLINE HYCLATE 71 50 35 126
CARVEDILOL 71 71 35 24
PREDNISONE 63 54 37 35
SPIRIVA 63 62 37 44
TRAMADOL HCL 62 59 39 16
METHYLPREDNISOLONE 57 45 40 160
CYMBALTA 57 37 40 51
BUPROPION HCL SR 56 34 42 171
LOVASTATIN 53 53 43 37
METOPROLOL SUCCINATE 51 39 44 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.